India's Pharmaceutical Exports

Country Profile

Sudan

Sudan is a growing market for Indian pharmaceuticals — $145M in FY 2025–26, with 2.1× growth over the past decade. Medicines accounts for 70% of shipments, with vaccines contributing $36.9M. The compound annual growth rate since FY2015 stands at 6.9%.

🇸🇩 $145M · 2.1× growth since FY2015 · 6.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$145M
Exports FY2025–26 DGCIS
2.1×
Growth FY2015→2026
6.9%
CAGR FY2015→2026
70%
Medicines Share
5
Product Categories Supplied
Sudan is a growing market for Indian pharmaceuticals — $145M in FY 2025–26, with 2.1× growth over the past decade. Medicines accounts for 70% of shipments, with vaccines contributing $36.9M. The compound annual growth rate since FY2015 stands at 6.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $102M (70.4%) Vaccines $36.9M (25.5%) Surgical & Hospital Supplies $3.62M (2.5%) Medicine Ingredients $1.37M (0.9%) Traditional & Herbal $1.01M (0.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Sudan in the RBI overseas direct investment dataset (2011–2026).